UK flag as shield

Ixekizumab for treating moderate to severe plaque psoriasis

Today NICE, England published final draft guidance recommending Ixekizumab for treating moderate to severe plaque psoriasis.¬† The draft guidance can be found here Ixekizumab is recommended as an option for treating plaque psoriasis in adults, only if: the disease is severe, as defined by a total Psoriasis Area and Severity Index (PASI) of 10 or…

Read More
UK flag as shield

uk: Treat moderate to severely active ulcerative colitis

Treatment¬† recommendation: To treat moderate to severely active ulcerative colitis a final guidance was published recommending vedolizumab (Entyvio, Takeda) Vedolizumab provides a further treatment option when conventional therapy or TNF-alpha inhibitors either don’t work well, has stopped working or can’t be tolerated. Vedolizumab is recommended on basis it is provided to the NHS at a…

Read More